cytochrome b561

01/01/2018 - "This study is the first to implicate cytochrome b561 in disease by showing that pathogenic mutations in CYB561 cause an as yet unknown disease in neurotransmitter metabolism causing orthostatic hypotension."

09/29/1995 - "Unexpected results on cytochrome b561 expression in cells of lymphocytic origin and its complex regulation in tumor cells provide new insights into cytochrome b561 gene regulation."
01/01/2010 - "Of note, Cytochrome b561 expression pattern correlated with known androgen regulated genes in epithelial transcriptome of primary prostate tumors. "
01/01/2010 - "Elevated expression of the cytochrome b561, a neuroendocrine vesicle protein, in castration resistant prostate tumors."
01/01/2023 - "The fourth group includes a subgroup of proteins with a conserved "KXXXXKXH" non-cytoplasmic loop motif that may be a substrate binding site and is present in a potential ferric reductase, human tumor suppressor cytochrome b561. "
05/28/2013 - "The candidate tumor suppressor 101F6 protein is a homologue of adrenal chromaffin granule cytochrome b561, which is involved in the electron transfer from cytosolic ascorbate to intravesicular monodehydroascorbate radical. "

08/01/2022 - "The expression of cytochrome B561 (CYB561) and its role in breast cancer (BC) prognosis remain unclear. "
10/01/2023 - "Cytochrome b561 regulates iron metabolism by activating the Akt/mTOR pathway to promote Breast Cancer Cells proliferation."
01/01/2021 - "Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer."

09/29/1995 - "However, in B-cell lymphomas such as Burkitt's and Daudi, the cytochrome b561 expression was completely shut down. "

01/01/2010 - "Four fold higher levels of the Cytochrome b561 was present in highly metastatic and androgen refractory LNCaP/C4-2 prostate cancer cells in comparison to androgen responsive and non-metastatic LNCaP cells. "
01/01/2010 - "Evaluation of gene expression profiles in CWR22 prostate tumor xenografts in nude mice revealed overexpression of the Cytochrome b561, a transmembrane electron transport protein abundant in neuroendocrine vesicles, in the castration recurrent prostate cancers (CRPC). "